Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Net Margin (2016 - 2025)

Historic Net Margin for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 21.22%.

  • Dexcom's Net Margin rose 76000.0% to 21.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 17.94%, marking a year-over-year increase of 36500.0%. This contributed to the annual value of 17.94% for FY2025, which is 36500.0% up from last year.
  • Dexcom's Net Margin amounted to 21.22% in Q4 2025, which was up 76000.0% from 23.47% recorded in Q3 2025.
  • Dexcom's 5-year Net Margin high stood at 24.78% for Q4 2023, and its period low was 0.76% during Q4 2021.
  • Moreover, its 5-year median value for Net Margin was 13.36% (2021), whereas its average is 13.45%.
  • Its Net Margin has fluctuated over the past 5 years, first tumbled by -730600bps in 2021, then surged by 135100bps in 2023.
  • Over the past 5 years, Dexcom's Net Margin (Quarter) stood at 0.76% in 2021, then surged by 1583bps to 11.26% in 2022, then soared by 120bps to 24.78% in 2023, then plummeted by -45bps to 13.62% in 2024, then surged by 56bps to 21.22% in 2025.
  • Its last three reported values are 21.22% in Q4 2025, 23.47% for Q3 2025, and 15.54% during Q2 2025.